Pathfinder Second Edition: Adventure Path Blood Lords #2 Graveclaw

Toil and Trouble! After stopping a poisonous plot against the living population of Graydirge, the player characters must seek out the hag pulling the strings from behind the scenes. Yet hags congregate in covens, and facing off against the insidious hag coven called the Graveclaw leads to a race across the undeadhaunted nation of Geb. From shadowed forests to an undersea temple, and from rustedout factories to university lecture halls, the characters must investigate the trails of misery and fear the hags leave in their wake. The characters must vanquish the Graveclaw to protect the residents of Gebor end up stewing in a hag's cauldron!

"Graveclaw" is a Pathfinder adventure for four 4thlevel characters. The adventure continues the Blood Lords Adventure Path, a sixpart monthly campaign in which the characters rise from skilled troubleshooters to join the Blood Lords who rule a nation of the dead. The adventure also includes an article exposing the secrets of hag covens and plenty of new rules for fighting against hags. New spells and new items complete the witch's brew in the coven's cookpot!

Each monthly fullcolor softcover Pathfinder Adventure Path volume contains an indepth adventure scenario, stats for several new monsters, and support articles meant to give Game Masters additional material to expand their campaign. Pathfinder Adventure Path volumes use the Open Game License and work with both the Pathfinder RPG and the world's oldest fantasy RPG.

Sales Points

• The thrilling second installment of an allnew sixvolume Pathfinder Adventure Path campaign, promising an easy onramp for new and experienced players and a thrilling new storyline set in the undead realm of Geb!
• Utilizes rules from the new Pathfinder Book of the Dead hardcover.
• Contains dozens of hours of exciting Pathfinder play, either as a standalone adventure or as part of the epic Blood Lords campaign!
• Adventure/sourcebook hybrid.
• Extensive marketing support throughout 2022.